| 17.1551 -0.125 (-0.72%) | 05-22 15:36 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.86 | 1-year : | 21.46 |
| Resists | First : | 17.86 | Second : | 18.37 |
| Pivot price | 17.74 |
|||
| Supports | First : | 17.04 | Second : | 14.17 |
| MAs | MA(5) : | 17.69 |
MA(20) : | 17.7 |
| MA(100) : | 17.13 |
MA(250) : | 17.08 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 34.2 |
D(3) : | 54.9 |
| RSI | RSI(14): 42.1 |
|||
| 52-week | High : | 20.03 | Low : | 13.86 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SBRA ] has closed above bottom band by 4.0%. Bollinger Bands are 6.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 18.13 - 18.23 | 18.23 - 18.31 |
| Low: | 16.96 - 17.08 | 17.08 - 17.18 |
| Close: | 17.1 - 17.28 | 17.28 - 17.44 |
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Thu, 22 May 2025
Sabra Health Care REIT director Michael Foster sells $200,376 in stock - Investing.com India
Thu, 22 May 2025
Lazard Asset Management LLC Boosts Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Thu, 22 May 2025
Nomura Holdings Inc. Takes $988,000 Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Wed, 21 May 2025
Jefferies Financial Group Inc. Buys Shares of 20,091 Sabra Health Care REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Wed, 21 May 2025
Nuveen Asset Management LLC Grows Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) - MarketBeat
Sun, 18 May 2025
Bank of America Corp DE Cuts Stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Real Estate
|
|
|
Industry:
REIT - Healthcare Facilities
|
|
| Shares Out | 238 (M) |
| Shares Float | 235 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 101.9 (%) |
| Shares Short | 18,580 (K) |
| Shares Short P.Month | 19,020 (K) |
| EPS | 0.6 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.35 |
| Profit Margin | 19.5 % |
| Operating Margin | 36.8 % |
| Return on Assets (ttm) | 3.1 % |
| Return on Equity (ttm) | 5.1 % |
| Qtrly Rev. Growth | 10.6 % |
| Gross Profit (p.s.) | 2.05 |
| Sales Per Share | 3.02 |
| EBITDA (p.s.) | 1.81 |
| Qtrly Earnings Growth | 54 % |
| Operating Cash Flow | 338 (M) |
| Levered Free Cash Flow | 271 (M) |
| PE Ratio | 28.57 |
| PEG Ratio | 0 |
| Price to Book value | 1.5 |
| Price to Sales | 5.66 |
| Price to Cash Flow | 12.06 |
| Dividend | 0.3 |
| Forward Dividend | 0 |
| Dividend Yield | 1.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|